It is well known that FGFR4 activates the mitogen-activated protein kinase and SRC homology 2 domain-containing phosphatase 2 signaling pathways, thereby maintaining the malignant phenotype in cancer cells [37, 38]. Here, WNK2 is linked to cancer.